- Home
- GALT vs CENX Comparison
GALT vs CENX Comparison
Compare GALT & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- CENX
- Stock Information
- Founded
- GALT 2000
- CENX 1995
- Country
- GALT United States
- CENX United States
- Employees
- GALT N/A
- CENX N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- CENX Aluminum
- Sector
- GALT Health Care
- CENX Industrials
- Exchange
- GALT Nasdaq
- CENX Nasdaq
- Market Cap
- GALT 147.8M
- CENX N/A
- IPO Year
- GALT N/A
- CENX 1996
- Fundamental
- Price
- GALT $1.04
- CENX $18.33
- Analyst Decision
- GALT Strong Buy
- CENX Buy
- Analyst Count
- GALT 1
- CENX 3
- Target Price
- GALT $11.00
- CENX $21.00
- AVG Volume (30 Days)
- GALT 1.1M
- CENX 915.2K
- Earning Date
- GALT 11-13-2024
- CENX 11-04-2024
- Dividend Yield
- GALT N/A
- CENX N/A
- EPS Growth
- GALT N/A
- CENX N/A
- EPS
- GALT N/A
- CENX 3.19
- Revenue
- GALT N/A
- CENX $2,101,699,999.00
- Revenue This Year
- GALT N/A
- CENX N/A
- Revenue Next Year
- GALT N/A
- CENX $12.05
- P/E Ratio
- GALT N/A
- CENX $5.78
- Revenue Growth
- GALT N/A
- CENX N/A
- 52 Week Low
- GALT $0.73
- CENX $9.65
- 52 Week High
- GALT $4.27
- CENX $25.39
- Technical
- Relative Strength Index (RSI)
- GALT 20.80
- CENX 31.86
- Support Level
- GALT $1.80
- CENX $23.25
- Resistance Level
- GALT $2.36
- CENX $24.22
- Average True Range (ATR)
- GALT 0.27
- CENX 1.14
- MACD
- GALT -0.08
- CENX -0.68
- Stochastic Oscillator
- GALT 15.07
- CENX 8.67
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.